Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

720 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

Qidong Hepatitis B Intervention Study

NCT00222664

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +17 more
Locations
  • Qidong Liver Cancer Institute Qidong, Jiangsu, China
  • Cancer Institute, Chinese Academy of Medical Sciences Beijing, China
  • Clinical Trial Service Unit and Epidemiological Studies Unit Oxford, United Kingdom
View Trial Details
Active, Not Recruiting

Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)

NCT06497504

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Orlando, Florida, United States
  • GSK Investigational Site West Palm Beach, Florida, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

NCT06537414

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site San Jose, California, United States
  • GSK Investigational Site Minneapolis, Minnesota, United States
  • GSK Investigational Site New York, United States
View all 80 locations
View Trial Details
Active, Not Recruiting

Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)

NCT04954859

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site San Jose, California, United States
  • GSK Investigational Site Colorado Springs, Colorado, United States
  • GSK Investigational Site Boston, Massachusetts, United States
View all 163 locations
View Trial Details
Active, Not Recruiting

HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B

NCT01796457

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • California Pacific Medical Center San Francisco, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • University of Minnesota Plymouth, Minnesota, United States
View Trial Details
Active, Not Recruiting

HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B

NCT01298037

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • California Pacific Medical Center San Francisco, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions